about
Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cellsbeta-dystrobrevin, a member of the dystrophin-related protein familyP2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophyChanges in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemiaSynthesis and characterization of variable-architecture thermosensitive polymers for complexation with DNA.G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.Aberrant location of inhibitory synaptic marker proteins in the hippocampus of dystrophin-deficient mice: implications for cognitive impairment in duchenne muscular dystrophy.Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockoutsA novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.Emerging vectors and targeting methods for nonviral gene therapy.Dystrobrevins in muscle and non-muscle tissues.Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.Store-operated calcium entry contributes to abnormal Ca²⁺ signalling in dystrophic mdx mouse myoblasts.Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles.Relationship between the affinity of PEO-PPO-PEO block copolymers for biological membranes and their cellular effects.P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatmentA functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice.Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells.Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion.Dystrophin: The dead calm of a dogma.Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas.Dystroglycan: brain localisation and chromosome mapping in the mouse.Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo.CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma.Mutation in dystrophin-encoding gene affects energy metabolism in mouse myoblasts.Intramuscular plasmid DNA injection can accelerate autoimmune responses.Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.Mechanisms of ATP- and glutamate-mediated calcium signaling in white matter astrocytes.Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro.Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity.Investigations of octylglyceryl dextran-graft-poly(lactic acid) nanoparticles for peptide delivery to the brain.Expression of alpha-dystrobrevin in blood-tissue barriers: sub-cellular localisation and molecular characterisation in normal and dystrophic mice.Differential expression of syntrophins and analysis of alternatively spliced dystrophin transcripts in the mouse brain.Structural diversity despite strong evolutionary conservation in the 5'-untranslated region of the P-type dystrophin transcript.Sustained activation of P2X7 induces MMP-2-evoked cleavage and functional purinoceptor inhibition.Impact of P2RX7 ablation on the morphological, mechanical and tissue properties of bones in a murine model of duchenne muscular dystrophy.Specific expression of G-dystrophin (Dp71) in the brain.Differential seizure-induced and developmental changes of neurexin expression.
P50
Q24647998-6DF6167B-428D-40B5-8802-5DBFE8CCFC03Q24682037-472254F5-B889-4DE1-BE4F-0E9C770E7490Q28550201-FBA87D71-066E-4F28-B657-99C0285BB952Q28576669-0A920B08-F002-4189-9773-DD7B614ABE41Q33267677-906793DA-8CAC-461D-8171-2518DEDE0504Q34369312-87EDE49F-EC8B-4750-BE4B-631C4C8B5E90Q35280143-FC0E4018-1F46-42A5-953F-02EC2454C109Q35853248-957A7EE7-2217-43D0-8179-0F8958391FF0Q35853255-24DA9879-2B85-4D31-97A4-C10F48881724Q36580613-397E91EA-5B52-4793-A0CC-9E187A715230Q36717600-8F1D5565-D47B-4F0E-83BA-90D6A0106148Q38829438-C5C1F5B6-340E-4464-8787-3227F61F1477Q38873713-8628A4BB-4BF8-41D4-9D4F-DB316B009DE0Q38912120-7B48EC24-EFCA-4489-8037-274001744522Q39075478-F958E5FD-DB65-4480-A8E7-286B0AA7F668Q39384996-5871885F-3EBF-411C-8B3B-B4235122F5B8Q39499956-B8DF4562-9F6C-44C1-880A-9E477F17100CQ39834758-0F74D5A1-3355-44E5-BCA1-B406CC5D5E10Q40296980-7A5D0758-28C2-43D8-91E7-69B0C301658BQ40394927-B1653C65-BCC3-44A7-AA46-3B34497CB05AQ40401861-6E629B0A-7D77-4B8E-A30E-27A55781576FQ40519985-0F65E753-06DE-4B61-BBA8-687B40194828Q41021360-C37AB3BF-1852-4505-AFA4-C42B9E3018B4Q41111332-CE704BD5-526C-4EAE-A561-BCF74C820141Q42011951-AC1A3EE1-4620-4701-9279-D6FB4AA7D17CQ42870698-6AA9D045-8D43-40A3-B4F9-A9DBE4809337Q45242416-04A0C4D0-5FF2-464A-9F70-F9A54775D6CAQ45880047-BED4C75F-E70B-4FED-AA96-2BEDDC2546E4Q46590020-3E86D6B3-E85E-4935-BA53-54E99BFC7CE3Q46738936-20CBE7D8-3FAF-4E31-95DE-BA22AB15653CQ47304250-E371DBF9-A670-4EC7-BE29-D5C62ED55BADQ48208814-8EDE106B-CDA9-490B-9A87-3E3DEBF1DF1AQ48247082-188ABC18-049E-46BA-B8F4-130553673806Q48462582-1A3E00E9-2294-42F6-9893-0013F5E9B47AQ48714342-5EB77A26-7975-484D-876C-7E0C02FF019FQ48939214-EACEC754-60DD-4039-8FDD-BA609F50DEDFQ49385617-B209F098-67D2-4135-ABC4-3079B7DF3863Q51131195-34BB7336-06F4-4D8D-9BE5-7DFFCA7FA9B4Q52016932-F1D1A822-1AEB-4553-A5D3-63558A4E2133Q52175757-9DD8DD60-FA04-464B-B12F-56D6A39C998D
P50
description
researcher, ORCID id # 0000-0003-3584-1654
@en
wetenschapper
@nl
name
Dariusz C Górecki
@ast
Dariusz C Górecki
@en
Dariusz C Górecki
@nl
type
label
Dariusz C Górecki
@ast
Dariusz C Górecki
@en
Dariusz C Górecki
@nl
prefLabel
Dariusz C Górecki
@ast
Dariusz C Górecki
@en
Dariusz C Górecki
@nl
P106
P31
P496
0000-0003-3584-1654